A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.
Identifieur interne : 002B20 ( PubMed/Curation ); précédent : 002B19; suivant : 002B21A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.
Auteurs : Alexis Boyd [États-Unis] ; Kimberly Y. Won ; Shannon K. Mcclintock ; Catherine V. Donovan ; Sandra J. Laney ; Steven A. Williams ; Nils Pilotte ; Thomas G. Streit ; Madsen V E. Beau De Rochars ; Patrick J. LammieSource :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2010.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Analyse de regroupements, Anticorps antihelminthe (sang), Antigènes d'helminthe (sang), Enfant, Enfant d'âge préscolaire, Enquêtes et questionnaires, Facteurs de risque, Femelle, Filaricides (usage thérapeutique), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (transmission), Filariose lymphatique (épidémiologie), Haïti (épidémiologie), Humains, Jeune adulte, Maladies endémiques, Mâle, Observance du traitement médicamenteux (), Sujet âgé, Sujet âgé de 80 ans ou plus.
- MESH :
- sang : Anticorps antihelminthe, Antigènes d'helminthe.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Filaricides, Filariose lymphatique.
- épidémiologie : Filariose lymphatique, Haïti.
- Adolescent, Adulte, Adulte d'âge moyen, Analyse de regroupements, Enfant, Enfant d'âge préscolaire, Enquêtes et questionnaires, Facteurs de risque, Femelle, Humains, Jeune adulte, Maladies endémiques, Mâle, Observance du traitement médicamenteux, Sujet âgé, Sujet âgé de 80 ans ou plus.
- Wicri :
- geographic : Haïti.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Helminth (blood), Antigens, Helminth (blood), Child, Child, Preschool, Cluster Analysis, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (transmission), Endemic Diseases, Female, Filaricides (therapeutic use), Haiti (epidemiology), Humans, Male, Medication Adherence (statistics & numerical data), Middle Aged, Risk Factors, Surveys and Questionnaires, Young Adult.
- MESH :
- chemical , blood : Antibodies, Helminth, Antigens, Helminth.
- geographic , epidemiology : Haiti.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- statistics & numerical data : Medication Adherence.
- chemical , therapeutic use : Filaricides.
- transmission : Elephantiasis, Filarial.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cluster Analysis, Endemic Diseases, Female, Humans, Male, Middle Aged, Risk Factors, Surveys and Questionnaires, Young Adult.
Abstract
Seven rounds of mass drug administration (MDA) have been administered in Leogane, Haiti, an area hyperendemic for lymphatic filariasis (LF). Sentinel site surveys showed that the prevalence of microfilaremia was reduced to <1% from levels as high as 15.5%, suggesting that transmission had been reduced. A separate 30-cluster survey of 2- to 4-year-old children was conducted to determine if MDA interrupted transmission. Antigen and antifilarial antibody prevalence were 14.3% and 19.7%, respectively. Follow-up surveys were done in 6 villages, including those selected for the cluster survey, to assess risk factors related to continued LF transmission and to pinpoint hotspots of transmission. One hundred houses were mapped in each village using GPS-enabled PDAs, and then 30 houses and 10 alternates were chosen for testing. All individuals in selected houses were asked to participate in a short survey about participation in MDA, history of residence in Leogane and general knowledge of LF. Survey teams returned to the houses at night to collect blood for antigen testing, microfilaremia and Bm14 antibody testing and collected mosquitoes from these communities in parallel. Antigen prevalence was highly variable among the 6 villages, with the highest being 38.2% (Dampus) and the lowest being 2.9% (Corail Lemaire); overall antigen prevalence was 18.5%. Initial cluster surveys of 2- to 4-year-old children were not related to community antigen prevalence. Nearest neighbor analysis found evidence of clustering of infection suggesting that LF infection was focal in distribution. Antigen prevalence among individuals who were systematically noncompliant with the MDAs, i.e. they had never participated, was significantly higher than among compliant individuals (p<0.05). A logistic regression model found that of the factors examined for association with infection, only noncompliance was significantly associated with infection. Thus, continuing transmission of LF seems to be linked to rates of systematic noncompliance.
DOI: 10.1371/journal.pntd.0000640
PubMed: 20351776
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B20
Links to Exploration step
pubmed:20351776Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.</title><author><name sortKey="Boyd, Alexis" sort="Boyd, Alexis" uniqKey="Boyd A" first="Alexis" last="Boyd">Alexis Boyd</name><affiliation wicri:level="1"><nlm:affiliation>Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea></affiliation></author><author><name sortKey="Won, Kimberly Y" sort="Won, Kimberly Y" uniqKey="Won K" first="Kimberly Y" last="Won">Kimberly Y. Won</name></author><author><name sortKey="Mcclintock, Shannon K" sort="Mcclintock, Shannon K" uniqKey="Mcclintock S" first="Shannon K" last="Mcclintock">Shannon K. Mcclintock</name></author><author><name sortKey="Donovan, Catherine V" sort="Donovan, Catherine V" uniqKey="Donovan C" first="Catherine V" last="Donovan">Catherine V. Donovan</name></author><author><name sortKey="Laney, Sandra J" sort="Laney, Sandra J" uniqKey="Laney S" first="Sandra J" last="Laney">Sandra J. Laney</name></author><author><name sortKey="Williams, Steven A" sort="Williams, Steven A" uniqKey="Williams S" first="Steven A" last="Williams">Steven A. Williams</name></author><author><name sortKey="Pilotte, Nils" sort="Pilotte, Nils" uniqKey="Pilotte N" first="Nils" last="Pilotte">Nils Pilotte</name></author><author><name sortKey="Streit, Thomas G" sort="Streit, Thomas G" uniqKey="Streit T" first="Thomas G" last="Streit">Thomas G. Streit</name></author><author><name sortKey="Beau De Rochars, Madsen V E" sort="Beau De Rochars, Madsen V E" uniqKey="Beau De Rochars M" first="Madsen V E" last="Beau De Rochars">Madsen V E. Beau De Rochars</name></author><author><name sortKey="Lammie, Patrick J" sort="Lammie, Patrick J" uniqKey="Lammie P" first="Patrick J" last="Lammie">Patrick J. Lammie</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20351776</idno><idno type="pmid">20351776</idno><idno type="doi">10.1371/journal.pntd.0000640</idno><idno type="wicri:Area/PubMed/Corpus">002B20</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B20</idno><idno type="wicri:Area/PubMed/Curation">002B20</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B20</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.</title><author><name sortKey="Boyd, Alexis" sort="Boyd, Alexis" uniqKey="Boyd A" first="Alexis" last="Boyd">Alexis Boyd</name><affiliation wicri:level="1"><nlm:affiliation>Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea></affiliation></author><author><name sortKey="Won, Kimberly Y" sort="Won, Kimberly Y" uniqKey="Won K" first="Kimberly Y" last="Won">Kimberly Y. Won</name></author><author><name sortKey="Mcclintock, Shannon K" sort="Mcclintock, Shannon K" uniqKey="Mcclintock S" first="Shannon K" last="Mcclintock">Shannon K. Mcclintock</name></author><author><name sortKey="Donovan, Catherine V" sort="Donovan, Catherine V" uniqKey="Donovan C" first="Catherine V" last="Donovan">Catherine V. Donovan</name></author><author><name sortKey="Laney, Sandra J" sort="Laney, Sandra J" uniqKey="Laney S" first="Sandra J" last="Laney">Sandra J. Laney</name></author><author><name sortKey="Williams, Steven A" sort="Williams, Steven A" uniqKey="Williams S" first="Steven A" last="Williams">Steven A. Williams</name></author><author><name sortKey="Pilotte, Nils" sort="Pilotte, Nils" uniqKey="Pilotte N" first="Nils" last="Pilotte">Nils Pilotte</name></author><author><name sortKey="Streit, Thomas G" sort="Streit, Thomas G" uniqKey="Streit T" first="Thomas G" last="Streit">Thomas G. Streit</name></author><author><name sortKey="Beau De Rochars, Madsen V E" sort="Beau De Rochars, Madsen V E" uniqKey="Beau De Rochars M" first="Madsen V E" last="Beau De Rochars">Madsen V E. Beau De Rochars</name></author><author><name sortKey="Lammie, Patrick J" sort="Lammie, Patrick J" uniqKey="Lammie P" first="Patrick J" last="Lammie">Patrick J. Lammie</name></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antibodies, Helminth (blood)</term><term>Antigens, Helminth (blood)</term><term>Child</term><term>Child, Preschool</term><term>Cluster Analysis</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (transmission)</term><term>Endemic Diseases</term><term>Female</term><term>Filaricides (therapeutic use)</term><term>Haiti (epidemiology)</term><term>Humans</term><term>Male</term><term>Medication Adherence (statistics & numerical data)</term><term>Middle Aged</term><term>Risk Factors</term><term>Surveys and Questionnaires</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de regroupements</term><term>Anticorps antihelminthe (sang)</term><term>Antigènes d'helminthe (sang)</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Enquêtes et questionnaires</term><term>Facteurs de risque</term><term>Femelle</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (transmission)</term><term>Filariose lymphatique (épidémiologie)</term><term>Haïti (épidémiologie)</term><term>Humains</term><term>Jeune adulte</term><term>Maladies endémiques</term><term>Mâle</term><term>Observance du traitement médicamenteux ()</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term><term>Antigens, Helminth</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Haiti</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term><term>Antigènes d'helminthe</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Medication Adherence</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Filaricides</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Haïti</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Cluster Analysis</term><term>Endemic Diseases</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Surveys and Questionnaires</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de regroupements</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Enquêtes et questionnaires</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Maladies endémiques</term><term>Mâle</term><term>Observance du traitement médicamenteux</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Haïti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Seven rounds of mass drug administration (MDA) have been administered in Leogane, Haiti, an area hyperendemic for lymphatic filariasis (LF). Sentinel site surveys showed that the prevalence of microfilaremia was reduced to <1% from levels as high as 15.5%, suggesting that transmission had been reduced. A separate 30-cluster survey of 2- to 4-year-old children was conducted to determine if MDA interrupted transmission. Antigen and antifilarial antibody prevalence were 14.3% and 19.7%, respectively. Follow-up surveys were done in 6 villages, including those selected for the cluster survey, to assess risk factors related to continued LF transmission and to pinpoint hotspots of transmission. One hundred houses were mapped in each village using GPS-enabled PDAs, and then 30 houses and 10 alternates were chosen for testing. All individuals in selected houses were asked to participate in a short survey about participation in MDA, history of residence in Leogane and general knowledge of LF. Survey teams returned to the houses at night to collect blood for antigen testing, microfilaremia and Bm14 antibody testing and collected mosquitoes from these communities in parallel. Antigen prevalence was highly variable among the 6 villages, with the highest being 38.2% (Dampus) and the lowest being 2.9% (Corail Lemaire); overall antigen prevalence was 18.5%. Initial cluster surveys of 2- to 4-year-old children were not related to community antigen prevalence. Nearest neighbor analysis found evidence of clustering of infection suggesting that LF infection was focal in distribution. Antigen prevalence among individuals who were systematically noncompliant with the MDAs, i.e. they had never participated, was significantly higher than among compliant individuals (p<0.05). A logistic regression model found that of the factors examined for association with infection, only noncompliance was significantly associated with infection. Thus, continuing transmission of LF seems to be linked to rates of systematic noncompliance.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20351776</PMID><DateCreated><Year>2010</Year><Month>03</Month><Day>30</Day></DateCreated><DateCompleted><Year>2010</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2010</Year><Month>Mar</Month><Day>23</Day></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.</ArticleTitle><Pagination><MedlinePgn>e640</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0000640</ELocationID><Abstract><AbstractText>Seven rounds of mass drug administration (MDA) have been administered in Leogane, Haiti, an area hyperendemic for lymphatic filariasis (LF). Sentinel site surveys showed that the prevalence of microfilaremia was reduced to <1% from levels as high as 15.5%, suggesting that transmission had been reduced. A separate 30-cluster survey of 2- to 4-year-old children was conducted to determine if MDA interrupted transmission. Antigen and antifilarial antibody prevalence were 14.3% and 19.7%, respectively. Follow-up surveys were done in 6 villages, including those selected for the cluster survey, to assess risk factors related to continued LF transmission and to pinpoint hotspots of transmission. One hundred houses were mapped in each village using GPS-enabled PDAs, and then 30 houses and 10 alternates were chosen for testing. All individuals in selected houses were asked to participate in a short survey about participation in MDA, history of residence in Leogane and general knowledge of LF. Survey teams returned to the houses at night to collect blood for antigen testing, microfilaremia and Bm14 antibody testing and collected mosquitoes from these communities in parallel. Antigen prevalence was highly variable among the 6 villages, with the highest being 38.2% (Dampus) and the lowest being 2.9% (Corail Lemaire); overall antigen prevalence was 18.5%. Initial cluster surveys of 2- to 4-year-old children were not related to community antigen prevalence. Nearest neighbor analysis found evidence of clustering of infection suggesting that LF infection was focal in distribution. Antigen prevalence among individuals who were systematically noncompliant with the MDAs, i.e. they had never participated, was significantly higher than among compliant individuals (p<0.05). A logistic regression model found that of the factors examined for association with infection, only noncompliance was significantly associated with infection. Thus, continuing transmission of LF seems to be linked to rates of systematic noncompliance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Won</LastName><ForeName>Kimberly Y</ForeName><Initials>KY</Initials></Author><Author ValidYN="Y"><LastName>McClintock</LastName><ForeName>Shannon K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Donovan</LastName><ForeName>Catherine V</ForeName><Initials>CV</Initials></Author><Author ValidYN="Y"><LastName>Laney</LastName><ForeName>Sandra J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Steven A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Pilotte</LastName><ForeName>Nils</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Streit</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials></Author><Author ValidYN="Y"><LastName>Beau de Rochars</LastName><ForeName>Madsen V E</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Lammie</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2005 Apr;99(3):237-42</RefSource><PMID Version="1">15829133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2004 May 5;3(1):3</RefSource><PMID Version="1">15128461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Emerg Infect Dis. 2007 Apr;13(4):608-10</RefSource><PMID Version="1">17553278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2006 Feb 24;5:2</RefSource><PMID Version="1">16504131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):41-4</RefSource><PMID Version="1">8153997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2008 Sep 12;83(37):333-41</RefSource><PMID Version="1">18788146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Aug;77(2):393-9</RefSource><PMID Version="1">17690421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2006 Jun;11(6):862-8</RefSource><PMID Version="1">16772008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009 Aug 25;3(8):e443</RefSource><PMID Version="1">19707279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008;2(10):e317</RefSource><PMID Version="1">18841205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 2008 Apr;136(4):520-4</RefSource><PMID Version="1">17579929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Dec;77(6):1069-73</RefSource><PMID Version="1">18165524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Entomol. 2009 Jul;46(4):873-80</RefSource><PMID Version="1">19645292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2008 Dec;102(12):1207-13</RefSource><PMID Version="1">18632125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2001 Dec;6(12):1062-9</RefSource><PMID Version="1">11737843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1995 Nov;172(5):1414-7</RefSource><PMID Version="1">7594692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2000 Dec;5(12):842-7</RefSource><PMID Version="1">11169272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2004 Sep 3;3(1):9</RefSource><PMID Version="1">15347425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2004 Oct;98(7):703-14</RefSource><PMID Version="1">15509424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 1997 Oct;13(10):401-4</RefSource><PMID Version="1">15275155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1997;75(6):491-503</RefSource><PMID Version="1">9509621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2004 Nov;71(5):598-601</RefSource><PMID Version="1">15569791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2000 Sep;5(9):591-4</RefSource><PMID Version="1">11044272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Feb;78(2):283-8</RefSource><PMID Version="1">18256430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2008 May 27;1(1):14</RefSource><PMID Version="1">18505577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 May;74(5):826-32</RefSource><PMID Version="1">16687688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2001 Oct 1;184(7):898-904</RefSource><PMID Version="1">11528594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2007 Nov 15;6:11</RefSource><PMID Version="1">18005398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2005 Nov;73(5):888-94</RefSource><PMID Version="1">16282299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 Nov;75(5):928-32</RefSource><PMID Version="1">17123989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008;2(6):e251</RefSource><PMID Version="1">18560545</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019353" MajorTopicYN="Y">Endemic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006205" MajorTopicYN="N" Type="Geographic">Haiti</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC2843627</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>06</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>02</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20351776</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0000640</ArticleId><ArticleId IdType="pmc">PMC2843627</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B20 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002B20 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:20351776
|texte= A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:20351776" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |